Resonance Health Ltd (ASX: RHT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Resonance Health Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$34.56 million
P/E Ratio
100.00
Dividend Yield
N/A
Shares Outstanding
461.15 million
Earnings per share
-0.001
Dividend per share
N/A
Year To Date Return
-49.29%
Earnings Yield
1.00%
Franking
N/A
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Resonance Health Ltd (ASX: RHT)
Latest News
Healthcare Shares
Here’s why the Resonance Health (ASX:RHT) share price is rocketing 36% today
Share Market News
Here’s why the Resonance Health (ASX:RHT) share price rocketed
Share Market News
Resonance Health (ASX:RHT) announces its share price is in trading halt
Share Market News
The Resonance Health (ASX:RHT) share price has rocketed up 9% today. Here’s why.
Share Market News
Why the Resonance Health (ASX:RHT) share price is shooting 39% higher today
Share Gainers
Why Afterpay, Creso Pharma, Healius, & Resonance Health shares are storming higher
Share Market News
Here’s why these 3 ASX shares are trading higher today
Share Market News
Why the Resonance Health share price is rocketing 20% higher
RHT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Resonance Health Ltd
Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver and HepaFat-Scan. The company's operating segment includes Services; Research and Development and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of revenue North America and Europe-Middle-East-Africa (EMEA) and also has a presence in Asia/Pacific.
RHT Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 11 Aug 2022 | $0.08 | $0.00 | 0.00% | 274,210 | $0.07 | $0.08 | $0.07 |
| 10 Aug 2022 | $0.07 | $0.00 | 0.00% | 10,000 | $0.07 | $0.07 | $0.07 |
| 08 Aug 2022 | $0.07 | $0.00 | 0.00% | 32,204 | $0.07 | $0.07 | $0.07 |
| 04 Aug 2022 | $0.07 | $0.00 | 0.00% | 7,100 | $0.07 | $0.07 | $0.07 |
| 02 Aug 2022 | $0.07 | $0.00 | 0.00% | 5,777 | $0.07 | $0.07 | $0.07 |
| 29 Jul 2022 | $0.07 | $0.00 | 0.00% | 78,316 | $0.07 | $0.07 | $0.07 |
| 25 Jul 2022 | $0.08 | $0.01 | 14.71% | 315,300 | $0.07 | $0.08 | $0.07 |
| 22 Jul 2022 | $0.07 | $0.00 | 0.00% | 99,230 | $0.07 | $0.07 | $0.07 |
| 21 Jul 2022 | $0.07 | $0.00 | 0.00% | 182,000 | $0.07 | $0.07 | $0.07 |
| 20 Jul 2022 | $0.07 | $0.00 | 0.00% | 28,700 | $0.07 | $0.07 | $0.07 |
| 15 Jul 2022 | $0.07 | $-0.01 | -13.33% | 397,752 | $0.08 | $0.08 | $0.07 |
| 14 Jul 2022 | $0.08 | $0.00 | 0.00% | 100,000 | $0.08 | $0.08 | $0.08 |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Martin Peter Blake | Non-Executive DirectorNon-Executive Chairman | Oct 2007 |
Dr Blake brings technical and industry experience to Resonance Health. He has been a Partner of Perth Radiological Clinic since 1997 and is currently the Chairman of that Company. He is Member of Risk Committee.
|
| Mr Mitchell MacDonald Wells | Executive DirectorManaging DirectorJoint Company Secretary | Feb 2018 |
Mr Wells has worked as a senior executive and as a Director of several ASX and US Nasdaq listed public companies. He has international project management and legal experience, having worked as a project manager and as a corporate and contracts consultant in Australia, the USA, and the United Kingdom. Mr Wells' career started as a lawyer working in law firms before transitioning to an executive role in the UK as a founding executive of London's bid to host the 2012 Olympic & Paralympic Games. He then worked as a project manager on the redevelopment of The O2 Arena precinct in London, regarded by many as Europe's entertainment precinct. Mitchell returned to Australia in 2008 to take up the role of COO, and ultimately CEO, of ASX listed Amadeus Energy Ltd, which was acquired by US based Lonestar Resources Inc. He then facilitated Lonestar's listing on the US Nasdaq and went on to serve as a Director of the Nasdaq listed parent and as Australia country representative. Mr Wells is also a commercial (aircraft) pilot and has served as Chair of two sizable not-for-profit organizations, including Guildford Grammar School.
|
| Mr Simon Panton | Non-Executive Director | Oct 2009 |
Mr Panton has been supporter of FerriScan technology over a number of years and is shareholder of Resonance Health. Mr Panton brings skills in business and marketing having run his own business. He is Member of Risk Committee.
|
| Dr Travis Baroni | Non-Executive Director | Nov 2016 |
Mr Baroni has experience across industrial research, commercialisation of technology, asset valuations and investment banking services. He has managed innovation development and technology strategy in a company setting as well as being an investor in early stage investments. He has worked in investment banking, providing advisory services to equity capital market transactions, corporate research and valuations to clients. He is Chairman of Risk Committee.
|
| Mr Nicholas (Nick) Allan | Chief Financial OfficerJoint Company Secretary | May 2021 |
-
|
| Ms Liesl Ellies | Joint Company Secretary | Apr 2022 |
-
|
| Nicholas (Nick) Allan | Chief Financial OfficerJoint Company Secretary |
-
|
|
| Liesl Ellies | Joint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Southam Investments 2003 Pty Ltd (Warwickshire Investment A/C) | 73,300,000 | 15.90% |
| HSBC Custody Nominees (Australia) Limited | 43,293,525 | 9.39% |
| Acuity Capital Investment Management Pty Ltd (Acuity Capital Holdings A/C) | 20,000,000 | 4.34% |
| Ms Alison Virginia Wesley (Wesley Family A/C) | 10,000,000 | 2.17% |
| Mr Paul John Van Dyk | 9,349,700 | 2.03% |
| Mr William Murray Thompson | 6,658,660 | 1.44% |
| Ms Jade Louise Thompson | 6,512,759 | 1.41% |
| Mr Bruce Alan Stevenson | 6,300,000 | 1.37% |
| Mr Helmut Rocker | 6,250,000 | 1.36% |
| Marcolongo Nominees Pty Ltd (Marcolongo Family A/C) | 5,186,200 | 1.12% |
| The Majobri Holdings Pty Ltd (The Majobri Family A/C) | 4,500,000 | 0.98% |
| Mr Thomas Psarakis | 4,434,777 | 0.96% |
| Mr Harish Garg | 4,001,245 | 0.87% |
| BNP Paribas Nominees Pty Ltd (IB AU Noms Retailclient DRP) | 3,890,663 | 0.84% |
| Dr Martin Peter Blake | 3,798,590 | 0.82% |
| Mr Vincent Oladele | 3,708,052 | 0.80% |
| Morgan Stanley Australia Securities (Nominee) Pty Limited (No 1 Account) | 3,588,012 | 0.78% |
| Fullerton Private Capital Pty Limited | 3,500,000 | 0.76% |
| The University Of Western Australia | 3,478,750 | 0.75% |
| Neweconomy Com Au Nominees Pty Limited (900 Account) | 3,389,575 | 0.74% |